Rinvoq ER 45 MG tablet UU 28S
Ended Awarded
- Contract number
- SPE2DB25FEHWT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,479
Award facts
- Contract value 100% obligated
- $42,478.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for RINVOQ ER 45 MG tablets (28-count unit of use packaging) with a ceiling value of $42,478.65. This firm fixed price delivery order, with an ultimate completion date of September 23, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was competitively procured without set-aside designations, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a substantial federal contract portfolio primarily supporting military and veteran healthcare systems. The parent Indefinite Delivery Contract valued at $999,999,999.00 and extending through December 2026 serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for RINVOQ, a rheumatoid arthritis treatment, exemplifies the company's role as a critical vendor for the Defense Health Agency and other government healthcare systems requiring specialty pharmaceutical products to support military medical readiness worldwide.
Quick answers
Who was awarded contract SPE2DB25FEHWT?
SPE2DB25FEHWT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FEHWT worth?
The government has obligated $42,479 on SPE2DB25FEHWT.
Is contract SPE2DB25FEHWT an order under another contract?
Yes. SPE2DB25FEHWT is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEHWT competed?
The extent of competition for SPE2DB25FEHWT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award